Clinical trials
Phase 3 Bone Diseases, Metabolic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 5 |
| 2003 | 5 |
| 2004 | 9 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Unknown status | 5 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 12 |
| Novartis Pharmaceuticals | 6 |
| Radius Health, Inc. | 5 |
| Massachusetts General Hospital | 4 |
| M.D. Anderson Cancer Center | 3 |
| Chinese University of Hong Kong | 2 |
| Genelabs Technologies | 2 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2 |
| University of Nebraska | 2 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Diseases, Metabolic | 68 |
| Osteoporosis | 40 |
| Osteoporosis, Postmenopausal | 11 |
| Fractures, Bone | 9 |
| Breast Neoplasms | 4 |
| Amenorrhea | 3 |
| Bone Diseases | 3 |
| Musculoskeletal Diseases | 3 |
| Anorexia Nervosa | 2 |
| Feeding and Eating Disorders | 2 |
Trials
Showing 26 to 50 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.